Dexcom, Inc. held its 2026 Annual Meeting of Stockholders, where shareholders elected twelve directors and ratified Deloitte & Touche LLP as the independent auditor. Stockholders also approved the company's executive compensation on a non-binding advisory basis, receiving 277,111,475 votes in favor and 36,664,959 votes against.
